The COVID Advisor

The Stratus variant, scientifically designated as XFG, is a sublineage of the Omicron family of SARS-CoV-2 (the virus causing COVID-19). It was first detected in Southeast Asia in January 2025 and classified by the World Health Organization (WHO) as a Variant Under Monitoring (VUM) on June 25, 2025. XFG is characterized by specific genetic mutations, including JF1 + S:T22N, S:S31P, S:R190S, S:R346T, S:K444R, S:V445R, S:F456L, S:N487D, S:Q493E, and S:T572I, which contribute to its increased transmissibility compared to some prior Omicron subvariants. It has a estimated daily growth advantage of about 6% over other circulating strains. The WHO's initial risk evaluation considers it a low public health risk overall, with no clear evidence of increased severity or immune evasion beyond existing Omicron variants. Symptoms Symptoms of the Stratus (XFG) variant are largely consistent with those of previous Omicron subvariants, though anecdotal reports and social media discussions highligh...

A sudden rise in younger people with early onset cancers which are more aggressive with more (and unusual) genetic change has been increasingly noted - colorectal, breast and GI tract cancers seem to lead the way. New Study Defines Mechanisms of Post-mRNA Vaccine “Turbo Cancer” Peer-reviewed research from Drs. Paul Marik and Justus Hope links COVID-19 mRNA vaccines to “turbo cancer,” detailing five biological pathways that may drive aggressive, fast-growing cancers. Dr. Paul Marik, chief scientific officer and co-founder of the Independent Medical Alliance, isn’t one to shy away from hard truths. In his video statement below, accompanying the release of a new peer-reviewed paper , he described what doctors and nurses around the world have been seeing since 2021: more aggressive cancers, affecting younger patients, and returning with a vengeance in people once in remission — often within weeks of a COVID-19 booster shot. The paper, co-authored ...

The Front Line COVID-19 Critical Care (FLCCC*) Alliance was initially formed as a working group during the early COVID-19 pandemic days in response to multiple early reports of COVID patients with an inexplicably high need for prolonged mechanical ventilation and an excessive death rate.  *The FLCCC Alliance is now the  Independent Medical Alliance Based on rapidly emerging clinical trials evidence, the FLCCC team has developed the   I-MASK+ protocol   ( is now divided into I-Prevent and I-Care protocols ) for prophylaxis and at home treatment of early stage COVID-19. Quercetin, zinc and a number of nutrients and drugs are part of this protocol, not only for critical care but also for prophylaxis and mild disease being treated at home. This article, we will dive deeper to provide the scientific background, related references and rationale of the FLCCC protocols. Update:  NB.1.8.1 COVID variant: Symptoms, Spread, and What You Need to Know  (June 2025) FLCCC ...